Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 002D779 ( Pmc/Corpus ); précédent : 002D778; suivant : 002D780 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Rehabilitation and exercise oncology program: translating research into a model of care</title>
<author>
<name sortKey="Dalzell, M A" sort="Dalzell, M A" uniqKey="Dalzell M" first="M. A." last="Dalzell">M. A. Dalzell</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Smirnow, N" sort="Smirnow, N" uniqKey="Smirnow N" first="N." last="Smirnow">N. Smirnow</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Sateren, W" sort="Sateren, W" uniqKey="Sateren W" first="W." last="Sateren">W. Sateren</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="af2-conc-24-e191">Rossy Cancer Network, Montreal, QC;</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="af3-conc-24-e191">Segal Cancer Centre, Jewish General Hospital, Montreal, QC.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Sintharaphone, A" sort="Sintharaphone, A" uniqKey="Sintharaphone A" first="A." last="Sintharaphone">A. Sintharaphone</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ibrahim, M" sort="Ibrahim, M" uniqKey="Ibrahim M" first="M." last="Ibrahim">M. Ibrahim</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Mastroianni, L" sort="Mastroianni, L" uniqKey="Mastroianni L" first="L." last="Mastroianni">L. Mastroianni</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vales Zambrano, L D" sort="Vales Zambrano, L D" uniqKey="Vales Zambrano L" first="L. D." last="Vales Zambrano">L. D. Vales Zambrano</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="O Rien, S" sort="O Rien, S" uniqKey="O Rien S" first="S." last="O Rien">S. O Rien</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">28680286</idno>
<idno type="pmc">5486391</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486391</idno>
<idno type="RBID">PMC:5486391</idno>
<idno type="doi">10.3747/co.24.3498</idno>
<date when="2017">2017</date>
<idno type="wicri:Area/Pmc/Corpus">002D77</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002D77</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Rehabilitation and exercise oncology program: translating research into a model of care</title>
<author>
<name sortKey="Dalzell, M A" sort="Dalzell, M A" uniqKey="Dalzell M" first="M. A." last="Dalzell">M. A. Dalzell</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Smirnow, N" sort="Smirnow, N" uniqKey="Smirnow N" first="N." last="Smirnow">N. Smirnow</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Sateren, W" sort="Sateren, W" uniqKey="Sateren W" first="W." last="Sateren">W. Sateren</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="af2-conc-24-e191">Rossy Cancer Network, Montreal, QC;</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="af3-conc-24-e191">Segal Cancer Centre, Jewish General Hospital, Montreal, QC.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Sintharaphone, A" sort="Sintharaphone, A" uniqKey="Sintharaphone A" first="A." last="Sintharaphone">A. Sintharaphone</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ibrahim, M" sort="Ibrahim, M" uniqKey="Ibrahim M" first="M." last="Ibrahim">M. Ibrahim</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Mastroianni, L" sort="Mastroianni, L" uniqKey="Mastroianni L" first="L." last="Mastroianni">L. Mastroianni</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vales Zambrano, L D" sort="Vales Zambrano, L D" uniqKey="Vales Zambrano L" first="L. D." last="Vales Zambrano">L. D. Vales Zambrano</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="O Rien, S" sort="O Rien, S" uniqKey="O Rien S" first="S." last="O Rien">S. O Rien</name>
<affiliation>
<nlm:aff id="af1-conc-24-e191">Hope and Cope, Jewish General Hospital, Montreal, QC;</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Current Oncology</title>
<idno type="ISSN">1198-0052</idno>
<idno type="eISSN">1718-7729</idno>
<imprint>
<date when="2017">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec>
<title>Introduction</title>
<p>The Rehabilitation and Exercise Oncology model of care (ActivOnco) was established to optimize cancer survivorship through exercise prescription and active lifestyle promotion, providing a transition of care from hospital to community. Patients having any cancer diagnosis, stage of disease, and treatment were eligible for evaluation and exercise prescription upon deterioration of performance status. The team of professionals included hospital-based physiotherapists proactively screening for rehabilitation needs, loss of functional independence, and exercise eligibility, plus exercise specialists in a community-based Wellness Centre to provide follow-up or direct access for post-treatment or non-complex patients.</p>
</sec>
<sec>
<title>Methods</title>
<p>From January 2011 to December 2015, the hospital team assessed 1635 patients representing all major cancer sites, and the Wellness Centre team evaluated and prescribed exercise for 1066 participants. Primary interventions provided were education about fatigue management, physical activity promotion, exercise prescription, fracture risk reduction, referral to specialized follow-up services (for example, occupational therapy, lymphedema clinic), and coordination for mobility aids and paratransit services.</p>
</sec>
<sec>
<title>Results and Conclusions</title>
<p>Implementation of the ActivOnco model of care showed that exercise alone is not a panacea for all functional deterioration associated with the cancer trajectory and its treatment. However, screening to identify rehabilitation needs combined with exercise prescription can effectively improve the quality of survivorship in cancer patients. Program developments are limited by the cost of human resources, lack of hospital-based physical resources, and lack of public funding, all of which significantly limit the scope and development of appropriate services.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Curr Oncol</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr Oncol</journal-id>
<journal-id journal-id-type="publisher-id">CO</journal-id>
<journal-title-group>
<journal-title>Current Oncology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1198-0052</issn>
<issn pub-type="epub">1718-7729</issn>
<publisher>
<publisher-name>Multimed Inc.</publisher-name>
<publisher-loc>66 Martin St. Milton, ON, Canada L9T 2R2</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28680286</article-id>
<article-id pub-id-type="pmc">5486391</article-id>
<article-id pub-id-type="doi">10.3747/co.24.3498</article-id>
<article-id pub-id-type="publisher-id">conc-24-e191</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
<subj-group subj-group-type="heading">
<subject>Cancer Rehabilitation and Survivorship</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Rehabilitation and exercise oncology program: translating research into a model of care</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dalzell</surname>
<given-names>M.A.</given-names>
</name>
<degrees>MSc BScPT</degrees>
<xref ref-type="aff" rid="af1-conc-24-e191">
<sup>*</sup>
</xref>
<xref ref-type="corresp" rid="c1-conc-24-e191"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smirnow</surname>
<given-names>N.</given-names>
</name>
<degrees>BScPT CLT</degrees>
<xref ref-type="aff" rid="af1-conc-24-e191">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sateren</surname>
<given-names>W.</given-names>
</name>
<degrees>MBA MPH</degrees>
<xref ref-type="aff" rid="af1-conc-24-e191">
<sup>*</sup>
</xref>
<xref ref-type="aff" rid="af2-conc-24-e191">
<sup></sup>
</xref>
<xref ref-type="aff" rid="af3-conc-24-e191">
<sup></sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sintharaphone</surname>
<given-names>A.</given-names>
</name>
<degrees>BSc</degrees>
<xref ref-type="aff" rid="af1-conc-24-e191">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ibrahim</surname>
<given-names>M.</given-names>
</name>
<degrees>MScPT CSLT</degrees>
<xref ref-type="aff" rid="af1-conc-24-e191">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mastroianni</surname>
<given-names>L.</given-names>
</name>
<degrees>BSc</degrees>
<xref ref-type="aff" rid="af1-conc-24-e191">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vales Zambrano</surname>
<given-names>L.D.</given-names>
</name>
<degrees>MScPT</degrees>
<xref ref-type="aff" rid="af1-conc-24-e191">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O’Brien</surname>
<given-names>S.</given-names>
</name>
<degrees>MA</degrees>
<xref ref-type="aff" rid="af1-conc-24-e191">
<sup>*</sup>
</xref>
</contrib>
<aff id="af1-conc-24-e191">
<label>*</label>
Hope and Cope, Jewish General Hospital, Montreal, QC;</aff>
<aff id="af2-conc-24-e191">
<label></label>
Rossy Cancer Network, Montreal, QC;</aff>
<aff id="af3-conc-24-e191">
<label></label>
Segal Cancer Centre, Jewish General Hospital, Montreal, QC.</aff>
</contrib-group>
<author-notes>
<corresp id="c1-conc-24-e191">Correspondence to: Mary-Ann Dalzell, 3755, chemin de la Côte-Sainte-Catherine, E-773, Montréal (Québec) H3T 1E2. E-mail:
<email>madalzell5@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>24</volume>
<issue>3</issue>
<fpage>e191</fpage>
<lpage>e198</lpage>
<permissions>
<copyright-statement>2017 Multimed Inc.</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>The Rehabilitation and Exercise Oncology model of care (ActivOnco) was established to optimize cancer survivorship through exercise prescription and active lifestyle promotion, providing a transition of care from hospital to community. Patients having any cancer diagnosis, stage of disease, and treatment were eligible for evaluation and exercise prescription upon deterioration of performance status. The team of professionals included hospital-based physiotherapists proactively screening for rehabilitation needs, loss of functional independence, and exercise eligibility, plus exercise specialists in a community-based Wellness Centre to provide follow-up or direct access for post-treatment or non-complex patients.</p>
</sec>
<sec>
<title>Methods</title>
<p>From January 2011 to December 2015, the hospital team assessed 1635 patients representing all major cancer sites, and the Wellness Centre team evaluated and prescribed exercise for 1066 participants. Primary interventions provided were education about fatigue management, physical activity promotion, exercise prescription, fracture risk reduction, referral to specialized follow-up services (for example, occupational therapy, lymphedema clinic), and coordination for mobility aids and paratransit services.</p>
</sec>
<sec>
<title>Results and Conclusions</title>
<p>Implementation of the ActivOnco model of care showed that exercise alone is not a panacea for all functional deterioration associated with the cancer trajectory and its treatment. However, screening to identify rehabilitation needs combined with exercise prescription can effectively improve the quality of survivorship in cancer patients. Program developments are limited by the cost of human resources, lack of hospital-based physical resources, and lack of public funding, all of which significantly limit the scope and development of appropriate services.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Oncology rehabilitation</kwd>
<kwd>exercise</kwd>
<kwd>models of care</kwd>
<kwd>survivorship</kwd>
<kwd>quality of life</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D779 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002D779 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024